fibrinogen has been researched along with Thrombotic Microangiopathies in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Levi, M; Thachil, J | 1 |
| Dixon, BP; Meir, K; Nitzan-Luques, A; Slae, M; Volovelsky, O; Zugayar, D | 1 |
| Erkan, D; James, JA; Merrill, JT; Winakur, J | 1 |
| Berling, I; Isbister, GK | 1 |
| Cho, G; Douglas, K; El-Ghariani, K; Howell, C; Potok, D; Rintala, T; Taylor, P; Watkins, S | 1 |
| Alpers, CE; Fogo, AB; Lusco, MA; Najafian, B | 1 |
| Bergman, GE; Dickneite, G; Joch, C; Pragst, I | 1 |
| Noris, M; Remuzzi, G | 1 |
4 review(s) available for fibrinogen and Thrombotic Microangiopathies
| Article | Year |
|---|---|
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Disseminated Intravascular Coagulation; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Mice; Pandemics; Pneumonia, Viral; Prothrombin Time; SARS-CoV-2; Thrombocytopenia; Thrombophilia; Thrombotic Microangiopathies | 2020 |
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
Topics: Anticoagulants; Antiviral Agents; Betacoronavirus; Complement System Proteins; Coronavirus Infections; COVID-19; Cytokines; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Pandemics; Plasma Exchange; Platelet Count; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Thrombosis; Thrombotic Microangiopathies | 2020 |
Hematologic effects and complications of snake envenoming.
Topics: Animals; Antivenins; Blood Coagulation; Blood Coagulation Factors; Elapidae; Enzyme Activation; Fibrinogen; Hemorrhagic Disorders; Heparin; Humans; Intracranial Hemorrhages; Plasma; Prothrombin Time; Snake Bites; Snake Venoms; Thrombotic Microangiopathies; Viperidae; Wounds and Injuries | 2015 |
Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P).
Topics: Adolescent; Adult; Animals; Female; Fibrinogen; Humans; Incidence; Infant, Newborn; Male; Pulmonary Embolism; Rabbits; Thrombosis; Thrombotic Microangiopathies; Young Adult | 2009 |
4 other study(ies) available for fibrinogen and Thrombotic Microangiopathies
| Article | Year |
|---|---|
Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease.
Topics: Atypical Hemolytic Uremic Syndrome; Fibrinogen; Hirschsprung Disease; Humans; Infant; Infant, Newborn; Kidney; Thrombotic Microangiopathies | 2021 |
Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.
Topics: Adult; Anemia, Sickle Cell; Autoimmune Diseases; Blood Component Removal; Blood Donors; Child; Citrates; Fibrinogen; Health Facilities; Humans; Hyperlipoproteinemia Type II; Leukocyte Reduction Procedures; Lipoproteins; Lymphoma, T-Cell, Cutaneous; Photopheresis; Plasma; Plasma Exchange; Quality Control; Syncope, Vasovagal; Thrombotic Microangiopathies | 2015 |
AJKD Atlas of Renal Pathology: Thrombotic Microangiopathy.
Topics: Complement C3; Fibrinogen; Glomerular Basement Membrane; Hemolytic-Uremic Syndrome; Humans; Immunoglobulin G; Immunoglobulin M; Kidney; Kidney Diseases; Microscopy; Microscopy, Electron; Microscopy, Fluorescence; Purpura, Thrombotic Thrombocytopenic; Thrombotic Microangiopathies | 2016 |
Thrombotic microangiopathy after kidney transplantation.
Topics: Autoantibodies; Blood Component Transfusion; Child; Complement Factor H; Complement Pathway, Alternative; Complement System Proteins; Escherichia coli Infections; Fibrinogen; Hemolytic-Uremic Syndrome; Humans; Kidney Transplantation; Liver Transplantation; Mutation; Plasma; Postoperative Complications; Recurrence; Thrombotic Microangiopathies; Treatment Failure; Treatment Outcome | 2010 |